The purpose of this article is to describe lessons from the first lymphoma clinical trial conducted by the AIDS Malignancy Consortium (AMC) in sub-Saharan Africa (SSA). AMC-068 was a randomized phase II comparison of intravenous versus oral chemotherapy for HIV-positive diffuse large B-cell lymphoma. Opening in 2016. AMC-068 planned to enroll 90 patients (45 per arm) in Kenya. https://unitedssports.shop/product-category/ball-elastic-goods-sliding-short/